Landscape Capital Management L.L.C. purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the 4th quarter, Holdings Channel reports. The fund purchased 46,109 shares of the company’s stock, valued at approximately $3,091,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of CTVA. Brighton Jones LLC grew its stake in Corteva by 307.2% in the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after purchasing an additional 11,760 shares in the last quarter. Woodline Partners LP grew its stake in Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in Corteva by 62.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after purchasing an additional 980 shares in the last quarter. Cresset Asset Management LLC grew its stake in Corteva by 2.6% in the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock valued at $526,000 after purchasing an additional 181 shares in the last quarter. Finally, Jump Financial LLC purchased a new position in Corteva in the second quarter valued at about $1,464,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have commented on the company. Citigroup boosted their target price on Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Deutsche Bank Aktiengesellschaft boosted their target price on Corteva from $90.00 to $100.00 in a research note on Monday, May 11th. Argus boosted their target price on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, March 31st. UBS Group lowered their target price on Corteva from $90.00 to $86.00 and set a “neutral” rating on the stock in a research note on Tuesday, June 9th. Finally, Mizuho boosted their target price on Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a research note on Wednesday, April 15th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $88.81.
Corteva Price Performance
NYSE CTVA opened at $76.14 on Monday. The company has a fifty day simple moving average of $80.39 and a 200 day simple moving average of $75.38. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63. The company has a market cap of $50.92 billion, a P/E ratio of 44.79, a P/E/G ratio of 2.33 and a beta of 0.57. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07.
Corteva (NYSE:CTVA – Get Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same quarter in the prior year, the company earned $1.13 EPS. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.
Corteva Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be paid a dividend of $0.18 per share. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is presently 42.35%.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
See Also
- Five stocks we like better than Corteva
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
